Clinical Trials Logo

Diastasis Recti clinical trials

View clinical trials related to Diastasis Recti.

Filter by:
  • Not yet recruiting  
  • Page 1

NCT ID: NCT06459752 Not yet recruiting - Diastasis Recti Clinical Trials

Combined Effects of Visceral Manipulation and Noble Technique on Post-partum Females With Diastasis Recti

Start date: June 2024
Phase: N/A
Study type: Interventional

Diastasis recti is characterized by an abnormal expansion of the gap between the medial sides of the rectus abdominis muscle and a lengthening of the linea alba (increased inter-recti distance). It is mainly caused by excessive intra-abdominal pressure. The abdominal muscles and connective structures expand from the growing uterus during pregnancy. Low back pain is a prevalent complaint that can result from various factors, including weakened core muscles and functional disability. The aim of the study would assess of combined effect of visceral manipulation and noble technique on Inter-rectal distance, low back pain and functional disability in post-partum females with diastasis recti.

NCT ID: NCT06214650 Not yet recruiting - Diastasis Recti Clinical Trials

Diastasis Recti Abdominis and a Combined Treatment With Abdominal Exercise and Radiofrequency

Start date: September 2024
Phase: N/A
Study type: Interventional

Diastasis recti abdominis is a pathology that appears in a high percentage of women during the postpartum period. However, there is little evidence about its treatment. The present protocol aims to evaluate the efficacy of radiofrequency as an alternative for the treatment of abdominal diastasis along with abdominal exercises compared to the only intervention through abdominal exercise. An aleatory clinical testing will be conducted where 44 women diagnosed with diastasis recti abdominis in the postpartum period will be recruited. A common exercise protocol will be applied for two groups of participants, and both of them will have to be able to carry out the activities autonomously at home. In addition, control sessions will be held weekly for both groups where one of the groups, the control group (n=22), will receive radiofrequency therapy with the machine in athermic mode, while the other group, the experimental group (n=22), will receive a weekly session under the established diathermy protocol. The sessions will last 30 minutes and will take place for 10 consecutive weeks. Three variables will be evaluated: the width of the diastasis measured in centimeters, life quality measured using the Short form (36) questionnaire, and the perception of the pain measured with the visual analogue scale. Three evaluations will be done: at the beginning of the study, after ten weeks and three months later.